LENZ THERAPEUTICS INC (LENZ) Institutional Ownership Changes & 13F Activity
LENZ THERAPEUTICS INC (LENZ). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Qube Research & Technologies Ltd, Citadel Advisors Llc, Bank Of America Corp, and Trexquant Investment Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +363,229 | — | 363,229 | $2.06M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +37,672 | +101.1% | 74,931 | $425.61K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -10,538 | -97.4% | 280 | $1.59K | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +12,289 | — | 12,289 | $69.80K | Q2 2026 | Aug 19, 2026 |
| Jefferies Financial Group Inc. | Buy | +200,300 | — | 200,300 | $1.14M | Q2 2026 | Aug 17, 2026 |
| Transamerica Financial Advisors, Llc | Buy | +28 | — | 28 | $159.00 | Q2 2026 | Aug 17, 2026 |
| Millennium Management Llc | Buy | +639,221 | +73.5% | 1,508,478 | $8.57M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +482,195 | — | 482,195 | $2.74M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -292,124 | -53.4% | 255,410 | $1.45M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +283,118 | +132.0% | 497,526 | $2.83M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +240,597 | +16.0% | 1,747,096 | $9.92M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -215,413 | -43.0% | 285,584 | $1.62M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +154,053 | — | 154,053 | $875.02K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -101,282 | -66.9% | 50,105 | $284.60K | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -100,950 | -86.3% | 16,061 | $91.23K | Q2 2026 | Aug 14, 2026 |
| Mangrove Partners Im, Llc | Buy | +96,749 | — | 96,749 | $549.53K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -90,412 | -40.9% | 130,625 | $741.95K | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +87,427 | +62.3% | 227,732 | $1.29M | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +57,917 | +264.5% | 79,811 | $448.54K | Q2 2026 | Aug 14, 2026 |
| Scoggin Management Lp | Buy | +50,000 | +40.0% | 175,000 | $994.00K | Q2 2026 | Aug 14, 2026 |
| Bridgeway Capital Management, Llc | Buy | +45,000 | — | 45,000 | $255.60K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +33,560 | +84.7% | 73,181 | $416.00K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -33,097 | -18.0% | 150,659 | $855.74K | Q2 2026 | Aug 14, 2026 |
| Atom Investors Lp | Buy | +31,826 | — | 31,826 | $180.77K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -27,847 | -29.2% | 67,388 | $382.00K | Q2 2026 | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | Sell | -24,613 | -5.3% | 438,882 | $2.49M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +23,263 | +15.6% | 172,807 | $981.54K | Q2 2026 | Aug 14, 2026 |
| Cerity Partners Llc | Buy | +20,571 | — | 20,571 | $116.84K | Q2 2026 | Aug 14, 2026 |
| Aigen Investment Management, Lp | Buy | +20,055 | — | 20,055 | $113.91K | Q2 2026 | Aug 14, 2026 |
| Susquehanna Fundamental Investments, Llc | Buy | +17,900 | — | 17,900 | $101.67K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about LENZ activity
Which institutional owners are buying LENZ?
Institutional owners buying LENZ include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in LENZ activity?
"Buy" means an investor increased their reported position in LENZ compared to the prior reporting period. This reflects growing exposure to LENZ THERAPEUTICS INC (LENZ) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in LENZ increasing?
Institutional interest in LENZ can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related LENZ Institutional Insights
- LENZ Overview
- LENZ 13F Institutional Holders
- LENZ Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- LENZ Insider Trading & SEC Form 4 Activity
- LENZ Articles
- Top Institutional Investor Stock Rankings